Related Experiment Video
Updated: Oct 27, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Sex Differences and COVID-19
Natalie Thomas1,2, Caroline Gurvich3, Jayashri Kulkarni3
1Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia. natalie.thomas@unimelb.edu.au.
Insights
Males face higher COVID-19 risks due to biological sex differences impacting key body systems. Understanding these sex-based disparities is crucial for developing effective COVID-19 treatments and vaccines.
Area of Science:
- Immunology
- Endocrinology
- Genetics
Background:
- Biological sex and gender influence disease outcomes, including COVID-19.
- Males exhibit higher risks for severe COVID-19 outcomes compared to females.
- Existing evidence suggests sex-based differences in endocrine, immune, and renin-angiotensin systems are implicated in COVID-19.
Purpose of the Study:
- To explore the sex and gender-based disparities in COVID-19 outcomes.
- To investigate the role of sex chromosomes and hormones in COVID-19 pathobiology.
- To identify potential therapeutic targets and enhance vaccine strategies for COVID-19.
Main Methods:
- Review of clinical observations and patient data for COVID-19 outcomes.
- Analysis of sex-based differences in endocrine, immune, and renin-angiotensin systems.
- Examination of genetic sex-based factors influencing SARS-CoV-2 infection.
Main Results:
- Males are at a higher risk for poorer COVID-19 disease outcomes.
- Sex chromosomes and sex hormones likely drive observed sex-based disparities.
- Differences in key physiological systems contribute to varied COVID-19 responses.
Conclusions:
- Understanding sex-based differences in endocrine, immune, and renin-angiotensin systems is critical for COVID-19 research.
- Exploiting these factors can lead to novel therapies and improved vaccine efficacy.
- Sex-specific approaches are necessary for managing and preventing severe COVID-19.
Abstract:
Biological sex and psychosocial gender both play a role in many disease outcomes, and the novel coronavirus disease (COVID-19) is no different. Clinical observations in COVID-19 patient data delineate clear disparities between males and females, indicating males are at a higher risk for poorer disease outcomes. Although we are yet to understand the sex and gender-based disparities specific to COVID-19, there is evidence for sex-based differences in the endocrine, immune and renin-angiotensin system, all systems implicated in COVID-19 outcomes. Such disparities are largely thought to be driven by sex chromosomes and modulating sex hormones, which are known to vary between sex, and across the reproductive lifespan. Understanding and exploiting these driving factors are critical to understanding the pathobiology of SARS-CoV-2 virus and may lead to the development of novel therapies and increase the efficacy of preventative vaccine strategies currently under development. This chapter focuses on the endocrine, immune and renin-angiotensin system and genetic sex-based differences that could account for the meaningful differences observed in the outcomes of the SARS-CoV-2 infection.
Related Concept Videos
Sexually Transmitted Infections
Socioemotional Experience and Gender Development
Panic Disorder
Single Nucleotide Polymorphisms-SNPs
Bias in Epidemiological Studies
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

